(Q33922904)

30 July 2017

1 reference

title

Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence? (English)

1 reference

30 July 2017

0 references

0 references

Longnecker R

1

1 reference

30 July 2017

1 January 2000

1 reference

Advances in Cancer Research

30 July 2017

1 reference

30 July 2017

79

1 reference

30 July 2017

175-200

1 reference

EBV persistence in memory B cells in vivo.

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

B cell development: signal transduction by antigen receptors and their surrogates.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Sequence polymorphisms between latent membrane proteins LMP1 and LMP2A do not correlate in EBV-associated reactive and malignant lympho-proliferations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

A children's cancer dependent on climatic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

The discovery of Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

New nomenclature for the Reth motif (or ARH1/TAM/ARAM/YXXL)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Signal transduction by the B cell antigen receptor and its coreceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Regulation of cell death protease caspase-9 by phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Mechanisms and consequences of activation of protein kinase B/Akt

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

BLNK: a central linker protein in B cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Csk suppression of Src involves movement of Csk to sites of Src activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

BLNK required for coupling Syk to PLC gamma 2 and Rac1-JNK in B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Is EBV persistence in vivo a model for B cell homeostasis?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Direct control of the Forkhead transcription factor AFX by protein kinase B

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Circulating Epstein-Barr virus-carrying B cells in acute malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

The terminal protein gene 2 of Epstein-Barr virus is transcribed from a bidirectional latent promoter region

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Regulation of Epstein-Barr virus latency by latent membrane protein 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

A novel form of Epstein-Barr virus latency in normal B cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

RAG-1-deficient mice have no mature B and T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Signaling through scaffold, anchoring, and adaptor proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Antigen receptor tail clue.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

SH2 domains recognize specific phosphopeptide sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Epstein-Barr virus lacking latent membrane protein 2 immortalizes B cells with efficiency indistinguishable from that of wild-type virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Structure and function of the WW domain.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Signal transduction by lymphocyte antigen receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

SLP-65: a new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Spontaneous outgrowth of epstein-barr virus-positive B-cell lines from circulating human B cells of different buoyant densities

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

5' Coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2800%2979006-3

7 January 2021

10.1016/S0065-230X(00)79006-3

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10818681